Professor John Koivukangas
Onesys Oy has an impressive track record in surgical and other clinical innovations. New developments and inventions broaden the applications of Onesys technology, with first products in the market, some ready for market and others at proof of concept phase. The business plan is based on investment milestones, sales and product spin-offs. Exit is M/A at three years or a clear plan for IPO at that time.
Onesys Oy
ChairmanMr Mikael Koivukangas
Onesys Oy has an impressive track record in surgical and other clinical innovations. New developments and inventions broaden the applications of Onesys technology, with first products in the market, some ready for market and others at proof of concept phase. The business plan is based on investment milestones, sales and product spin-offs. Exit is M/A at three years or a clear plan for IPO at that time.
Onesys Oy
Mr Mika Koivunen
Intertek is the leading quality solutions provider to industries worldwide.
From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value to customers’ products, processes and assets. With a network of more than 1,000 laboratories and offices and over 35,000 people in more than 100 countries, Intertek supports companies’ success in a global marketplace. Intertek helps its customers to meet end users’ expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide.
Visit www.intertek.com.
Intertek
Sales ManagerMr Panu Korhonen
We are developing a new carephone that integrates extended battery life and GSM module.
- The company is managed by its three founding members
- TUOHI carephone’s development started in 2013
- Extended battery life (micro amperage power consumption) and GSM module integration form the product's core
- Customers’ requirements contribute the rest of the design
- Field testing in Q1-Q2 2014
- Commercialization in Q3-Q4 2014
- The Finnish government has granted 50 000 euro development subsidy for the FY2013 through ELY